Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
- Status
- TERMINATED
- Phase
- PHASE2
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lonafarnib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Artesunate in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Faslodex Registry: Fulvestrant in Current Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Circulating Tumor Cells in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin
- Status
- TERMINATED
- Phase
- PHASE2